Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-03-20
1986-11-25
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514807, 530315, A61K 3734, C07K 716
Patent
active
046249435
ABSTRACT:
Certain new vasopressin-like peptides which have structures characterized by having a bisaminoalkylbenzene present in the vasopressin tail at the 7- or 8-position retain vasopressin antagonist activity. A species of the invention is [1-.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-8-1',4'-bis(aminomethyl)benzene-9-de sglycinamide]-vasopressin.
REFERENCES:
patent: 4367225 (1983-01-01), Manning et al.
patent: 4399125 (1983-08-01), Manning et al.
patent: 4491577 (1985-01-01), Manning et al.
M. Manning et al., Nature, 308 652 (1984).
Callahan James F.
Moore Michael L.
Yim Nelson C.
Edgerton William H.
Lourie Alan D.
Phillips Delbert R.
SmithKline Beckman Corporation
Suter Stuart R.
LandOfFree
Aromatic basic-tailed vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aromatic basic-tailed vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aromatic basic-tailed vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1158604